Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, has announced an exclusive commercial distribution agreement in the United States with Responsive Arthroscopy, an innovative medical device company specialising in sports soft tissue repair solutions. This strategic agreement strengthens Johnson & Johnson MedTech’s sports platform, enhancing its soft tissue portfolio to meet the rising demand for advanced solutions in the rapidly growing sports soft tissue repair market.
“Our relationship with Responsive Arthroscopy is a significant step in expanding our leadership in orthopaedics and advancing our sports soft tissue offerings,” said Aldo Denti, Company Group Chairman, Orthopaedics, Johnson & Johnson MedTech. “This collaboration allows us to deliver a broader range of cutting-edge tools that empower surgeons in shoulder, foot and ankle procedures. We’re excited to drive value in this rapidly growing segment and remain committed to advancing patient care in meaningful ways.”
By combining Johnson & Johnson MedTech’s expertise in orthopaedic innovation with Responsive Arthroscopy’s advanced technologies, this agreement will provide healthcare providers with a more comprehensive set of tools to respond to evolving needs.